Spark Therapeutics (ONCE) Misses Q3 EPS by 28c

Spark Therapeutics (NASDAQ: ONCE) reported Q3 EPS of ($1.26), $0.28 worse than the analyst estimate of ($0.98).

For earnings history and earnings-related data on Spark Therapeutics (ONCE) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery